Stem Cell Research (Jul 2021)

An induced pluripotent stem cell line (NCATS-CL9075) from a patient carrying compound heterozygote mutations, p.R390P and p.L318P, in the NGLY1 gene

  • Manisha Pradhan,
  • Atena Farkhondeh,
  • Yu-Shan Cheng,
  • Miao Xu,
  • Jeanette Beers,
  • Jizhong Zou,
  • Chengyu Liu,
  • Matthew Might,
  • Steven Rodems,
  • Karsten Baumgärtel,
  • Wei Zheng

Journal volume & issue
Vol. 54
p. 102400

Abstract

Read online

NGLY1 deficiency is a rare disorder caused by mutations in the NGLY1 gene which codes for the highly conserved N-glycanase1 (NGLY1). This enzyme functions in cytosolic deglycosylation of N- linked glycoproteins. An induced pluripotent stem cell (iPSC) line was generated from the dermal fibroblasts of a 2-year-old patient carrying compound heterozygous mutations, p.R390P and p.L318P in the NGLY1 gene. This cell-based iPSC disease model provides a resource to study disease pathophysiology and to develop a cell-based disease model for drug development for NGLY1 patients.